MOTS-c

Quick Facts

Introduction

MOTS-c (Mitochondrial Open-reading-frame of the Twelve S rRNA type-c) is one of a small family of mitochondrial-derived peptides (MDPs) — short peptides encoded not in the nucleus but within the mitochondrial genome itself. Its discovery reframed the mitochondrion as more than a power plant: a source of signaling molecules that communicate with the rest of the cell and even with distant tissues. In research it is studied primarily for its association with the master metabolic sensor AMPK, and it is closely grouped with the other best-known mitochondrial-derived peptide, Humanin.

The conceptual appeal of MOTS-c is that it represents a form of retrograde signaling from mitochondria to the nucleus. Rather than acting only locally, MOTS-c is studied as a peptide that can translocate to the nucleus under metabolic stress and influence the expression of stress-adaptive genes — a mechanism that connects it to broader research on metabolic flexibility, exercise adaptation, and aging. It overlaps in research interest with mitochondria-targeted compounds such as SS-31 and metabolic tools like BAM-15.

This profile covers what MOTS-c is, its molecular characteristics as a 16-residue mitochondrial-derived peptide, the AMPK-centered mechanism it engages, the metabolic and exercise research it appears in, and how it compares with related mitochondrial and metabolic compounds. Related entries are catalogued in the peptide database.

What is MOTS-c?

MOTS-c is a 16-amino-acid peptide whose coding sequence lies within the mitochondrial 12S ribosomal RNA gene. This is unusual: the overwhelming majority of cellular peptides are encoded by nuclear DNA, but MOTS-c (like Humanin) is a product of the mitochondrial genome, placing it in the distinct category of mitochondrial-derived peptides.

Functionally, MOTS-c is studied as a regulator of metabolic homeostasis. It is detectable in circulation, which is why researchers describe it as having both local (within the cell) and systemic (hormone-like) signaling roles. Its levels and activity have been studied in the contexts of exercise, aging, and metabolic stress.

Molecular and structural characteristics

MOTS-c is a short, basic peptide (sequence MRWQEMGYIFYPRKLR) with several positively charged residues that are relevant to its ability to interact with nucleic acids and to translocate to the nucleus under stress. Its small size and mitochondrial origin are its defining structural features; unlike larger signaling peptides, it carries no complex post-translational scaffolding.

As a peptide, MOTS-c is handled with the standard reconstitution workflow used for the compounds catalogued in the peptide database, in contrast to the small-molecule metabolic agents it is sometimes compared with such as BAM-15.

Mechanism of action

The central mechanism associated with MOTS-c is activation of AMP-activated protein kinase (AMPK), the cell's principal energy-sensing pathway. AMPK is switched on when cellular energy charge falls, and it then promotes catabolic, energy-generating processes — glucose uptake, fatty-acid oxidation, and mitochondrial efficiency — while restraining energy-consuming ones. MOTS-c is studied as an upstream signal that tilts cells toward this AMPK-driven metabolic state.

A key upstream node in this picture is the folate-methionine one-carbon cycle. Research has reported that MOTS-c influences this pathway in a way that leads to accumulation of AICAR, an endogenous AMPK activator — providing a biochemical link between MOTS-c and AMPK activation. This metabolic-intermediate mechanism distinguishes MOTS-c from peptides that act through cell-surface receptors.

Perhaps the most striking feature is MOTS-c's reported nuclear translocation. Under metabolic stress (for example glucose restriction or oxidative stress), MOTS-c is described as moving from the cytosol into the nucleus, where it interacts with stress-responsive transcription factors and helps regulate antioxidant and metabolic gene programs. This makes MOTS-c a candidate mediator of mitochondrial-to-nuclear retrograde signaling, a theme it shares conceptually with Humanin.

• Activation of the AMPK energy-sensing pathway.
• Modulation of the folate-methionine one-carbon cycle (AICAR accumulation).
• Enhanced glucose uptake and metabolic flexibility.
• Stress-induced translocation to the nucleus.
• Regulation of antioxidant and stress-response gene programs.

Metabolic homeostasis research

The foundational research on MOTS-c characterized it as a regulator of insulin sensitivity and glucose metabolism. In preclinical models, MOTS-c administration was associated with improved glucose handling and protection against diet-induced insulin resistance and weight gain, with the effects attributed to AMPK-driven enhancement of muscle glucose utilization. This is the work that established MOTS-c as a metabolic peptide rather than a purely local mitochondrial factor.

Because its mechanism centers on metabolic flexibility — the ability of tissues to switch efficiently between fuel sources — MOTS-c is studied in the same broad conversation as other metabolic compounds, including the ERR agonist SLU-PP-332 and the uncoupler BAM-15. Each engages cellular energetics differently, but all are examined for associations with improved metabolic health in research models.

Exercise and aging research

A major research strand frames MOTS-c as an exercise-induced peptide. Studies have reported that circulating and skeletal-muscle MOTS-c levels rise with exercise, and that MOTS-c is associated with the metabolic adaptations of physical activity — positioning it as a possible molecular participant in exercise's benefits. In aging research, MOTS-c administration has been studied for associations with improved physical capacity and resistance to age-related metabolic decline in rodent models.

This exercise-and-aging framing is what links MOTS-c to the broader field of mitochondrial-derived peptides and longevity, the same field that gave rise to interest in Humanin. Because mitochondrial function declines with age, peptides that support mitochondrial signaling are studied as candidate modulators of healthspan — strictly as a research concept, not an established intervention.

Comparison: MOTS-c vs Humanin vs SS-31

MOTS-c is most usefully compared with Humanin, the other principal mitochondrial-derived peptide, and with SS-31, a synthetic mitochondria-targeted peptide. All three concern mitochondrial biology, but they differ in origin and mechanism.

MOTS-c and Humanin are both natural mitochondrial-derived peptides, while SS-31 is a synthetic compound designed to localize to the mitochondrial inner membrane. Full entries for Humanin and SS-31 are available, and related compounds are catalogued in the peptide database.

Half-life and pharmacokinetic considerations

As a short, unmodified peptide, MOTS-c is expected to have a relatively brief circulating half-life subject to peptidase degradation, which is typical of small native peptides. Research has detected endogenous MOTS-c in plasma, indicating it functions as a circulating signal, but precise human pharmacokinetic parameters for administered MOTS-c are not well established.

Because much of its activity involves intracellular and nuclear events, researchers treat the relationship between circulating levels and downstream effects as indirect: the AMPK activation and gene-expression changes it drives can outlast its presence in circulation. As with other peptides, findings are interpreted in the context of the specific model and administration scheme used.

Reconstitution and handling considerations

Lyophilized MOTS-c is reconstituted with sterile or bacteriostatic water, added slowly down the vial wall and swirled gently rather than shaken to protect the short peptide. The reconstituted solution should be clear; cloudiness or particulates indicate it should be discarded.

Working concentrations are selected so research volumes are convenient and reproducible. The reconstitution calculator and reconstitution guide describe the general method.

• Add diluent slowly; swirl gently rather than shaking.
• Confirm the solution is clear before use.
• Use reconstituted material within a limited window.
• Protect from light and excess warmth.

Storage considerations

Lyophilized MOTS-c is most stable frozen at −20 °C, kept dry and away from light. Once reconstituted, it is refrigerated at 2–8 °C and used within a limited window; aliquoting reduces how often a given solution is cycled through freeze–thaw.

Research limitations

MOTS-c is a research compound whose biology, while increasingly well characterized, is still being mapped. Much of the evidence comes from rodent and cell studies, and the precise upstream triggers, receptors, and tissue-specific roles of MOTS-c remain active research questions. Robust human outcome data are not established. It is described here strictly for research reference.

• Evidence is largely preclinical; human outcome data are limited.
• Upstream triggers and any receptor for MOTS-c are still being defined.
• Reported effects are model-, dose-, and design-dependent.
• Pharmacokinetics of administered MOTS-c are not well established.
• It is not an approved therapy and is described solely for research reference.

Frequently Asked Questions

Related Research Profiles

References

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015.Source
2. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021.
3. Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. 2018.